Abstract
Background: Immune responses including Microglia and macrophage activation and peripheral immune cells infiltration have been founded in the central nervous system (CNS) in recent years. Thus, the traditional view of the adult brain as an immune-privileged organ has been changed.
Methods: A systematic literature search was performed using Pubmed and Embase electronic databases without any limitations for a retrospective analysis. Results: The increase a number of studies indicated that the PD-1(programmed cell death-1)/PD-Ls signal pathway played an important role in regulating the immunopathogenesis of brain after injured. The relevant knowledges about PD-1/PD-Ls signal pathway, and potential effect with immune cells, cerebral ischemia, brain tumors and multiple sclerosis were reviewed in this paper. Conclusion: PD-1/PD-Ls played important roles in maintaining immunity balance and the development and prognosis of CNS diseases, but the specific mechanism was still not well understood.Keywords: CNS disorders, glioblastoma, immunopathogenesis, ischemia, multiple sclerosis, PD-1/PD-Ls.
Graphical Abstract
Current Drug Delivery
Title:PD-1/PD-Ls: A New Target for Regulating Immunopathogenesis in Central Nervous System Disorders
Volume: 14 Issue: 6
Author(s): Jie Wu, Zhengquan Yu and Gang Chen*
Affiliation:
- Department of Neurosurgery, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006,China
Keywords: CNS disorders, glioblastoma, immunopathogenesis, ischemia, multiple sclerosis, PD-1/PD-Ls.
Abstract: Background: Immune responses including Microglia and macrophage activation and peripheral immune cells infiltration have been founded in the central nervous system (CNS) in recent years. Thus, the traditional view of the adult brain as an immune-privileged organ has been changed.
Methods: A systematic literature search was performed using Pubmed and Embase electronic databases without any limitations for a retrospective analysis. Results: The increase a number of studies indicated that the PD-1(programmed cell death-1)/PD-Ls signal pathway played an important role in regulating the immunopathogenesis of brain after injured. The relevant knowledges about PD-1/PD-Ls signal pathway, and potential effect with immune cells, cerebral ischemia, brain tumors and multiple sclerosis were reviewed in this paper. Conclusion: PD-1/PD-Ls played important roles in maintaining immunity balance and the development and prognosis of CNS diseases, but the specific mechanism was still not well understood.Export Options
About this article
Cite this article as:
Wu Jie, Yu Zhengquan and Chen Gang*, PD-1/PD-Ls: A New Target for Regulating Immunopathogenesis in Central Nervous System Disorders, Current Drug Delivery 2017; 14 (6) . https://dx.doi.org/10.2174/1567201814666161123152311
DOI https://dx.doi.org/10.2174/1567201814666161123152311 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Atypical PKCι as Target for Glioblastoma Therapy
Current Cancer Drug Targets Structural and Mechanistic Bases of the Anticancer Activity of Natural Aporphinoid Alkaloids
Current Topics in Medicinal Chemistry Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials
Current Cancer Drug Targets NOTCH Signaling as a Novel Cancer Therapeutic Target
Current Cancer Drug Targets Suppression of HIV Replication In Vitro by CpG and CpG Conjugated to the Non Toxic B Subunit of Cholera Toxin
Current HIV Research A Mini Review on Interactions Between Neural Stem Cells and Biomaterials
Recent Patents on Regenerative Medicine Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges
Current Vascular Pharmacology Molecular Mechanisms of Anti-cancer Activities of β-elemene: Targeting Hallmarks of Cancer
Anti-Cancer Agents in Medicinal Chemistry Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome
Current Psychiatry Reviews Targeting PPARalpha in Alzheimer's Disease
Current Alzheimer Research The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas
Current Cancer Drug Targets Meet Our Associate Editorial Board Member
Current Drug Delivery Utilizing Ultrasound to Transiently Increase Blood-Brain Barrier Permeability, Modulate of the Tight Junction Proteins, and Alter Cytoskeletal Structure
Current Neurovascular Research The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Current Pharmaceutical Design A Systems Biology Road Map for the Discovery of Drugs Targeting Cancer Cell Metabolism
Current Pharmaceutical Design Endostatin: Preclinical Development as an Anticancer Agent
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Radiation and Gene Therapy: Rays of Hope for the New Millennium?
Current Gene Therapy Neuroprotection by Estrogen and Progesterone in Traumatic Brain Injury and Spinal Cord Injury
Current Neuropharmacology Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy <i>Lophira alata</i> Suppresses Phorbol Ester-Mediated Increase in Cell Growth via Inhibition of Protein Kinase C-α/Akt in Glioblastoma Cells
Anti-Cancer Agents in Medicinal Chemistry